Star Therapeutics
South San Francisco, US · 18 known investors
Find your way into Star Therapeutics
97 people in our graph share verified history with the Star Therapeutics team — schools, employers, funds. One of them is your warm intro.
Joseph Jeongunlockedknows Adam Rosenthal · together at The Boston Consulting Group (overlapped)
×11knows the team · via The Boston Consulting Group
Star Therapeutics develops treatments aimed at addressing real-world patient needs.
Founders & leadership
AR
Adam RosenthalinCEO and FounderAdam Rosenthal founded Star Therapeutics after leading multiple successful therapeutic development programs; his prior companies, including Vega Therapeutics, True North Therapeutics, and iPierian, were acquired for a combined $3.55 billion.
NS
Nancy StaglianoCo-founder
MC
Michelle CarpenterExecutive
SP
Sandip PanickerExecutive
SR
Scott RobertsoninChief Business Officer & Chief Financial Officer
GP
Board
JH
Jason HaflerBoard director
CG
Carl GordonBoard director
AN
Amrit NagpalBoard director
BS
Beth SeidenbergBoard director
MK
Maha KatabiBoard director
MF
Matthew FustBoard director
Investors · 18
Frazier Life SciencesPalo Alto
OrbiMedNew York · $1M – $75M
RA CapitalBoston
Sanofi VenturesCambridge · $5M
Sofinnova VenturesMenlo Park · $100K – $15M
Agent Capitalreported · 2 sourcesWaltham
Blue Owl CapitalreportedNew York
Catalio Capital ManagementreportedNew York
Cowen Healthcare InvestmentsreportedNew York
Janus Henderson InvestorsreportedNew York
New Leaf Venture PartnersreportedNew York
NYBC VenturesreportedNew York
REDMILEreportedSan Francisco
Viking Global InvestorsreportedStamford
Westlake Village BioPartnersreportedLos Angeles · $100K – $5Mvia Beth Seidenberg · board
Also in the syndicate · 3
Cormorant Asset ManagementGordonMD Global InvestmentsQatar Investment Authority (QIA)
Funding
SEC filings, press & company announcements$250M disclosed across 2 of 4 rounds · 2023–2025
- Undisclosed amountSeries DOct 2025
Sanofi Ventures (lead), Viking Global Investors (lead), Frazier Life Sciences, GordonMD Global Investments, Janus Henderson Investors
Source ↗ - $125MSeries DSep 2025 · 3 sources
Sanofi Ventures (lead), Viking Global Investors (lead), Agent Capital, Blue Owl Capital, Catalio Capital Management, Cormorant Asset Management, Frazier Life Sciences, GordonMD Global Investments, Janus Henderson Investors, New Leaf Venture Partners, NYBC Ventures, OrbiMed, Qatar Investment Authority (QIA), RA Capital Management, Redmile Group
Source ↗
▶$125MraisedOct 2025 · 21 investors · OtherRule 506(b)
▶$125MraisedOct 2025 · 21 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Jason HaflerDirector
- Nancy StaglianoDirector
- Michelle CarpenterExecutive Officer
- Carl GordonDirector
- Matthew FustDirector
- Amrit NagpalDirector
- Beth SeidenbergDirector
- Sandip PanickerExecutive Officer
- Scott RobertsonExecutive Officer
- Adam RosenthalExecutive Officer, Director
- Maha KatabiDirector
- Gary PatouExecutive Officer
- Offering amount
- $125M
- Amount sold
- $125M
- First sale
- Sep 2025
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Star Therapeutics do?
- Star Therapeutics develops treatments aimed at addressing real-world patient needs.
- Who founded Star Therapeutics?
- Star Therapeutics was founded by Adam Rosenthal, Nancy Stagliano.
- Who are Star Therapeutics's investors?
- Star Therapeutics's investors include Frazier Life Sciences, OrbiMed, RA Capital, Sanofi Ventures, Sofinnova Ventures, Agent Capital, Blue Owl Capital, Catalio Capital Management and 7 more.
- How much funding has Star Therapeutics raised?
- Star Therapeutics has disclosed $250M raised across 2 of its 4 known rounds.
- Where is Star Therapeutics headquartered?
- Star Therapeutics is headquartered in South San Francisco, US.